CDH2 and breast carcinoma: A marked decrease in E-cadherin and increase in N-cadherin and Vimentin was observed in alpelisib-resistant cell lines (Figure 1G-H), Therefore, we have successfully established the alpelisib-resistant breast cancer cell line model.